News from the hybrid EASD 2022 congress, 19 - 23 Sept - online and in Stockholm, Sweden.
Prof. John Buse, MD, PhD
SGLT2i reduces outcomes in HFmrEF and HFpEF regardless of glycemic status
Pardeep Jhund, MD, PhD
Marta Seghieri, MD
Prof. Peter Rossing, MD
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.